NAD+, DNA Repair, and Cellular Stress Responses

What this page ties together

The preceding pages on this hub each cover one NAD+-dependent enzyme family in isolation: PARPs, sirtuins, and CD38. In a real cell, these systems operate together and interact — this page describes how they connect around DNA damage and cellular stress, and then addresses directly a specific chain of reasoning that shows up often in NAD+ marketing but does not hold up scientifically.

How NAD+-dependent enzymes respond to cellular stress, together

When a cell experiences DNA damage — from oxidative stress, radiation, replication errors, or other sources — PARP enzymes are rapidly activated at the damage site, consuming NAD+ as they help organize the local chromatin and recruit repair machinery.[1] Because PARPs and sirtuins draw on the same nuclear NAD+ pool, heavy PARP activation during a significant stress event can reduce the NAD+ available to sirtuins operating in the same compartment, a competitive relationship demonstrated directly in mouse experiments.[2] Separately, oxidative stress and inflammatory signaling are linked to increased CD38 activity, which consumes NAD+ through an entirely different route.[3] Put together, significant cellular stress can draw down NAD+ from multiple directions simultaneously — this integrated picture, drawn from established enzymology and preclinical research, is why NAD+ availability is discussed as relevant to how well cells manage stress and damage.

The inference this page exists to correct

A specific chain of reasoning appears often in popular and marketing writing about NAD+ supplements: NAD+-dependent enzymes participate in DNA repair and stress responses → therefore raising NAD+ with a supplement repairs DNA or reverses cellular aging. This inference is not scientifically valid, for a specific, explainable reason: participating in a process is not the same as being the rate-limiting factor that controls the outcome of that process in a healthy person. PARP1 is activated by actual DNA damage, not by ambient NAD+ levels — a cell with no DNA damage doesn't do more "repair" just because more NAD+ is available, because there's nothing to repair.[1] Sirtuin activity depends on NAD+, but sirtuin activity increasing is not the same statement as "DNA gets repaired" or "aging reverses" — those are much larger, specific claims that would each need their own direct evidence.[1] And CD38's role in aging-related NAD+ decline is, as covered on its own page, causally established in mice but only observationally linked in humans.[3]

What would actually be needed to support the marketing claim

To scientifically support a claim that NMN supplementation "repairs DNA" or "reverses aging" in humans, a study would need to directly measure a validated marker of DNA damage or genomic stability (not just NAD+ levels) in human participants, before and after NMN supplementation, against a placebo control, ideally over a duration long enough to be meaningful. No such study exists among the human NMN trials referenced on this hub — see NMN Dosage for the complete list of what these trials actually measured, which does not include DNA repair or genomic stability outcomes. Until that evidence exists, "participates in DNA repair" and "repairs DNA" remain two different claims, and this hub keeps them separate.

Related reading

For each enzyme family individually, see NAD+ and PARPs, NAD+ and Sirtuins, and NAD+ and CD38. For why NAD+ declines with age more broadly, see Why Does NAD+ Decline With Age?. For what human trials actually measured, see NMN Dosage and NMN Safety and Side Effects.